article thumbnail

Wellness in 2023 Is About Connections, Mental Health and Science – Global Wellness Summit’s 2023 Trends

Health Populi

Consumers’ wellness life-flows and demands in 2023 will go well beyond exercise resolutions, eating more greens, and intermittent fasting as a foodstyle. Being Missourian in spirit and intent: seeking the science and the evidence.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Let’s look back even further to 2013 to examine one definition of patient engagement: Health Affairs defines patient engagement as combining patient activation with interventions designed to increase and promote positive patient behavior, such as obtaining preventive care or exercising regularly, hopefully to lower costs.

BioTech 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

If surprise medical bills, out-of-network hassles, and waiting times for services persist, we may see this happen as patients-as-payors exercise their consumer muscles. Will consumers cross that cost-and-trust chasm and express similar outrage with the hospital sector as they’ve shown for a decade vis-a-vis Big Pharma?

article thumbnail

Digital Health's Silk Road: Will more Chinese HealthTech companies expand to Europe?

Lloyd Price

A digital health platform for patients with diabetes that uses artificial intelligence to track patients' blood sugar levels and provide personalized advice on diet and exercise. Enlighten is a biotech company that is developing gene-editing therapies for cancer and other diseases.

article thumbnail

Health SXSW 2018 | The 33 charts Super Guide

33 Charts - Digital Health

So if you want to know if the latest diet or exercise program is right for you? Advancements in biotech promise to transcend human limitations and end disability as we know it; from optogenetic interfaces with the human nervous system to synthetic appendages that move and feel like biological counterparts! Come hear what the data says.

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

When this occurred, it didn’t cause more than a ripple of interest outside biotech. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S. citizens’ personal data.